Nektar Therapeutics (NKTR)
67.28
-1.30
(-1.90%)
USD |
NASDAQ |
May 22, 14:13
Nektar Therapeutics EPS Diluted (Quarterly) : -1.815 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| Aquestive Therapeutics, Inc. | -0.0657 |
| Boston Scientific Corp. | 0.897 |
| Esperion Therapeutics, Inc. | -0.1002 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.90M |
| Revenue (Quarterly) | 10.86M |
| Total Expenses (Quarterly) | 55.76M |
| Enterprise Value | 761.30M |
| Gross Profit Margin (Quarterly) | 98.61% |
| Profit Margin (Quarterly) | -413.4% |
| Earnings Yield | -12.52% |
| Normalized Earnings Yield | -12.00 |